@ShahidNShah
For accurate monitoring of Epstein-Barr virus (EBV) in transplant patients
The cobas® EBV test is a diagnostic tool used by healthcare professionals to assess the risk of infection in transplant patients. The test is designed to provide reliable, standardized, and high-quality results for improved management of transplant patients. It is intended for use on the automated cobas® 5800/6800/8800 Systems.
The cobas® EBV test has several features and benefits, including standardization, state-of-the-art design, and efficiency, flexibility, and simplicity. The test results are traceable to the WHO International Standard and reported in IU/mL, which improves harmonization in testing results across hospitals and institutions. The test also has a dual-target assay design, which provides reliable and reproducible results, and helps with clinical decision making. Furthermore, the cobas® EBV test can be used to perform critical transplant testing (CMV, EBV, BKV) from a single sample on the cobas® 5800/6800/8800 Systems, with an industry-leading menu, absolute automation and proven performance, which makes the process more efficient and flexible for the healthcare professionals.
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 5, 2024 at 12:21pm